Облигации LLY
Ниже вы найдёте список корпоративных облигаций ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1. Инвесторы часто выбирают облигации компаний за их повышенную стабильность в периоды волнений на рынках. Изучите цены, доходность и другие данные, чтобы найти подходящие инвестиции.
Инструмент | Доходность к погашению % | Объём | Цена % | Купонная доходность % | Срок погашения | Задолженность | Номинал | Мин. деноминация | Эмитент |
---|---|---|---|---|---|---|---|---|---|
7,68% | 0 | 53,83% | 1,63% | 2043-09-14 | 250 M GBP | 1 000,00 GBP | 100 000,00 GBP | Eli Lilly & Co. | |
6,98% | 1,01 M | 56,88% | 2,25% | 2050-05-15 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
6,90% | 6,15 M | 54,73% | 2,50% | 2060-09-15 | 850 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
6,62% | 0 | 99,61% | 2,75% | 2025-06-01 | 560,65 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
6,11% | 20 K | 78,37% | 3,70% | 2045-03-01 | 386,8 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
6,11% | 0 | 78,39% | 4,15% | 2059-03-15 | 591,29 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
6,10% | 0 | 79,11% | 3,95% | 2049-03-15 | 958,15 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
6,08% | 22 K | 79,90% | 3,95% | 2047-05-15 | 346,95 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
5,93% | 0 | 84,34% | 3,88% | 2039-03-15 | 240,25 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
5,79% | 120 K | 90,02% | 4,95% | 2063-02-27 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
5,75% | 1,54 M | 92,14% | 5,10% | 2064-02-09 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
5,75% | 621 K | 90,66% | 4,88% | 2053-02-27 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
5,67% | 15 K | 90,48% | 4,65% | 2044-06-15 | 38,34 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
5,66% | 524 K | 94,34% | 5,20% | 2064-08-14 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
5,64% | 2,28 M | 93,49% | 5,05% | 2054-08-14 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
5,63% | 797 K | 93,04% | 5,00% | 2054-02-09 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
5,59% | 1,8 M | 100,17% | 5,60% | 2065-02-12 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
5,48% | 1,98 M | 100,19% | 5,50% | 2055-02-12 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
5,34% | 0 | 50,98% | 1,38% | 2061-09-14 | 700 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
5,12% | 15 K | 106,38% | 5,95% | 2037-11-15 | 266,83 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
5,11% | 15 K | 99,91% | 5,00% | 2026-02-27 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
4,97% | 400 K | 112,61% | 6,77% | 2036-01-01 | 158,56 M USD | 1 000,00 USD | 1 000,00 USD | Eli Lilly & Co. | |
4,88% | 3,86 M | 98,18% | 4,60% | 2034-08-14 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
4,87% | 34,45 M | 101,54% | 5,10% | 2035-02-12 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
4,87% | 1,93 M | 105,14% | 5,55% | 2037-03-15 | 444,73 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
4,85% | 5,52 M | 99,07% | 4,70% | 2034-02-09 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
4,78% | 0 | 57,32% | 1,13% | 2051-09-14 | 500 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
4,63% | 3,22 M | 100,42% | 4,70% | 2033-02-27 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
4,51% | 10,54 M | 102,04% | 4,90% | 2032-02-12 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
4,37% | 0 | 96,69% | 3,38% | 2029-03-15 | 930,56 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
4,30% | 0 | 68,93% | 1,70% | 2049-11-01 | 1 B EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
4,25% | 7,86 M | 102,02% | 4,75% | 2030-02-12 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
4,14% | 10,15 M | 100,24% | 4,20% | 2029-08-14 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
4,10% | 672 K | 101,31% | 4,50% | 2029-02-09 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
4,10% | 5 M | 98,11% | 3,10% | 2027-05-15 | 401,45 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
4,02% | 35 K | 101,33% | 4,55% | 2028-02-12 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
3,97% | 51 K | 102,69% | 5,50% | 2027-03-15 | 364,32 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
3,95% | 1,9 M | 100,93% | 4,50% | 2027-02-09 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
3,93% | 4,34 M | 100,47% | 4,15% | 2027-08-14 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
3,79% | 206 K | 100,34% | 7,13% | 2025-06-01 | 217,47 M USD | 1 000,00 USD | 5 000,00 USD | Eli Lilly & Co. | |
3,26% | 0 | 81,81% | 0,50% | 2033-09-14 | 600 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
3,07% | 0 | 86,69% | 0,63% | 2031-11-01 | 600 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
2,76% | 0 | 97,14% | 2,13% | 2030-06-03 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
2,24% | 0 | 99,34% | 1,63% | 2026-06-02 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
0,32% | 0 | 100,39% | 0,45% | 2028-05-24 | 400 M CHF | 5 000,00 CHF | 5 000,00 CHF | Eli Lilly & Co. |